# clm_12CF2E7419A7

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: quarterly_revenue  
value: 2,493,200,000 United States dollar  
valid_from: 2023-06-30  
valid_to: 2023-09-30  
published: 2023-08-02  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_25F0B0F08F89  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals quarterly revenue: 2,493,200,000 United States dollar", as of 2023-06-30 (until 2023-09-30). Claim clm_12CF2E7419A7, https://asof.is/claim/clm_12CF2E7419A7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532023000021/0000875320-23-000021-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2023, filed 2023-08-02  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532023000021/0000875320-23-000021-index.htm (primary, SEC EDGAR 10-Q Q2 FY2023, published 2023-08-02)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_revenue | 2,374,800,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_12CF2E7419A7](/claim/clm_12CF2E7419A7.md) | [clm_56F24DCACD81](/claim/clm_56F24DCACD81.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.